D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 66 Citations 18,707 186 World Ranking 1815 National Ranking 893

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Immune system
  • Gene

Hans Schreiber mainly focuses on Immunology, Antigen, Cancer research, Stromal cell and Cancer cell. In most of his Immunology studies, his work intersects topics such as Cancer. His study in Antigen is interdisciplinary in nature, drawing from both Molecular biology, Monoclonal antibody and T cell.

His research in Cancer research intersects with topics in Tumor progression, Chemotaxis, Tumor antigen and In vivo. The Stromal cell study which covers Bone marrow that intersects with Breast cancer, Epithelioma, Metastasis and Carcinoma. The concepts of his Cancer cell study are interwoven with issues in Cytotoxic T cell and Virology.

His most cited work include:

  • Innate and adaptive immune cells in the tumor microenvironment (1787 citations)
  • The terminology issue for myeloid-derived suppressor cells. (505 citations)
  • Inflammation as a tumor promoter in cancer induction. (468 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Antigen, Cancer research, Immune system and Cancer. The study incorporates disciplines such as Cancer cell and Cytotoxic T cell in addition to Immunology. He combines subjects such as Molecular biology, Antibody and Tumor antigen with his study of Antigen.

As a part of the same scientific family, Hans Schreiber mostly works in the field of Cancer research, focusing on In vitro and, on occasion, Virology. His work carried out in the field of Immune system brings together such families of science as Tumor progression and Fibrosarcoma. In his study, Respiratory tract is inextricably linked to Pathology, which falls within the broad field of Cancer.

He most often published in these fields:

  • Immunology (51.72%)
  • Antigen (49.26%)
  • Cancer research (33.50%)

What were the highlights of his more recent work (between 2008-2020)?

  • Cancer research (33.50%)
  • Immunology (51.72%)
  • Cancer (20.20%)

In recent papers he was focusing on the following fields of study:

Hans Schreiber mainly investigates Cancer research, Immunology, Cancer, Antigen and T cell. He has included themes like Cancer cell, Interleukin 21 and Tumor antigen in his Cancer research study. His Immunology study frequently links to other fields, such as Macrophage.

His work in Cancer covers topics such as Adoptive cell transfer which are related to areas like Mutation. His work carried out in the field of Antigen brings together such families of science as Cell biology, Chimeric antigen receptor and T-cell receptor. He has researched T cell in several fields, including Cytotoxic T cell, Cell culture and Vaccination.

Between 2008 and 2020, his most popular works were:

  • Innate and adaptive immune cells in the tumor microenvironment (1787 citations)
  • Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. (264 citations)
  • Classification of current anticancer immunotherapies (249 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Immune system

The scientist’s investigation covers issues in Immunology, Cancer research, Cancer, Antigen and Cancer cell. His study in T cell and Interferon is carried out as part of his studies in Immunology. Hans Schreiber specializes in Cancer research, namely Tumor microenvironment.

Hans Schreiber combines subjects such as Cytotoxic T cell and Interleukin 21 with his study of Tumor microenvironment. His research in Antigen intersects with topics in Tn antigen, Chimeric antigen receptor and Immune system. His biological study deals with issues like Stromal cell, which deal with fields such as Paracrine Communication and Tumor growth.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Innate and adaptive immune cells in the tumor microenvironment

Thomas F. Gajewski;Hans Schreiber;Yang Xin Fu.
Nature Immunology (2013)

2942 Citations

The terminology issue for myeloid-derived suppressor cells.

Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo.
Cancer Research (2007)

836 Citations

Inflammation as a tumor promoter in cancer induction.

Mary Philip;Donald A. Rowley;Hans Schreiber.
Seminars in Cancer Biology (2004)

770 Citations

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

Ping Yu;Youjin Lee;Wenhua Liu;Thomas Krausz.
Journal of Experimental Medicine (2005)

584 Citations

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

Markus Gerhard;Hartmut Juhl;Holger Kalthoff;Hans W. Schreiber.
Journal of Clinical Oncology (1994)

578 Citations

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

G Torre-Amione;R D Beauchamp;H Koeppen;B H Park.
Proceedings of the National Academy of Sciences of the United States of America (1990)

562 Citations

CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

Dominik Mumberg;Paul A. Monach;Sherry Wanderling;Mary Philip.
Proceedings of the National Academy of Sciences of the United States of America (1999)

518 Citations

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

J L Urban;H M Shepard;J L Rothstein;B J Sugarman.
Proceedings of the National Academy of Sciences of the United States of America (1986)

514 Citations

Classification of current anticancer immunotherapies

Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Oncotarget (2014)

464 Citations

Inhibition of tumor growth by elimination of granulocytes.

Lisa A. Pekarek;Barbara A. Starr;Alicia Y. Toledano;Hans Schreiber.
Journal of Experimental Medicine (1995)

427 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hans Schreiber

Thomas Blankenstein

Thomas Blankenstein

Max Delbrück Center for Molecular Medicine

Publications: 97

Yang-Xin Fu

Yang-Xin Fu

Tsinghua University

Publications: 62

Thomas F. Gajewski

Thomas F. Gajewski

University of Chicago

Publications: 51

Vincenzo Bronte

Vincenzo Bronte

University of Verona

Publications: 51

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 44

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 44

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 43

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 41

Mario P. Colombo

Mario P. Colombo

University of Milan

Publications: 35

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 34

Dmitry I. Gabrilovich

Dmitry I. Gabrilovich

AstraZeneca (United Kingdom)

Publications: 31

Ralph R. Weichselbaum

Ralph R. Weichselbaum

University of Chicago

Publications: 31

David M. Kranz

David M. Kranz

University of Illinois at Urbana-Champaign

Publications: 30

Laurence Zitvogel

Laurence Zitvogel

University of Paris-Saclay

Publications: 30

David H. Munn

David H. Munn

Augusta University

Publications: 29

Suzanne Ostrand-Rosenberg

Suzanne Ostrand-Rosenberg

University of Maryland, Baltimore County

Publications: 28

Trending Scientists

Alfredo Cuzzocrea

Alfredo Cuzzocrea

University of Calabria

Sutanu Sarkar

Sutanu Sarkar

University of California, San Diego

Brian R. Crane

Brian R. Crane

Cornell University

Norman M. Edelstein

Norman M. Edelstein

Lawrence Berkeley National Laboratory

Gerald B. Stringfellow

Gerald B. Stringfellow

University of Utah

Leonard A. Herzenberg

Leonard A. Herzenberg

Stanford University

Matthijs Verhage

Matthijs Verhage

Vrije Universiteit Amsterdam

Martin D. Ryan

Martin D. Ryan

University of St Andrews

Stefan Spring

Stefan Spring

Leibniz Association

Brad Spellberg

Brad Spellberg

University of Southern California

Olaf Pfannkuche

Olaf Pfannkuche

GEOMAR Helmholtz Centre for Ocean Research Kiel

David R. Marchant

David R. Marchant

Boston University

Joseph M. Suflita

Joseph M. Suflita

University of Oklahoma

Rae Silver

Rae Silver

Columbia University

Claudia Buss

Claudia Buss

University of California, Irvine

Jörn Wilms

Jörn Wilms

University of Erlangen-Nuremberg

Something went wrong. Please try again later.